Last reviewed · How we verify
Systane Free
At a glance
| Generic name | Systane Free |
|---|---|
| Sponsor | Southern California College of Optometry at Marshall B. Ketchum University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- SYSTANE® PRO vs. MIEBO™ in Dry Eye Disease (PHASE4)
- Quantifying Ocular Surface Aberrations After Tear Film Interventions (PHASE4)
- Systane® Ultra Preservative Free Lubricant Eye Drops (NA)
- Evaluation of the Safety and Tolerability of Ocular Lubricants (NA)
- Systane® Complete Preservative Free Lubricant Eye Drops (NA)
- Artificial Tears, Tear Lipids and Tear Film Dynamics (PHASE4)
- Systane® Hydration PF and Systane® Hydration Preserved (NA)
- Hyaluronic Acid-containing Artificial Tears in Post-cataract Surgery Dry Eye Disease (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Systane Free CI brief — competitive landscape report
- Systane Free updates RSS · CI watch RSS
- Southern California College of Optometry at Marshall B. Ketchum University portfolio CI